Device
AquaBeam System
AquaBeam System is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
NCT02505919
completednot_applicable
French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
NCT03191734
completednot_applicable
AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia
NCT03167294
completednot_applicable
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II
NCT03125889
completednot_applicable
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia
NCT03125863
Clinical Trials (5)
Showing 5 of 5 trials
NCT02505919Not Applicable
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
NCT03191734Not Applicable
French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
NCT03167294Not Applicable
AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia
NCT03125889Not Applicable
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II
NCT03125863Not Applicable
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5